Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cue Biopharma, Inc. - Common Stock
(NQ:
CUE
)
0.5950
+0.0542 (+10.02%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cue Biopharma, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 19, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
November 03, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
October 09, 2025
Via
Benzinga
Cue Biopharma Inc (NASDAQ:CUE) Q2 2025 Earnings: Revenue Surpasses Estimates, Loss Narrower Than Expected
↗
August 12, 2025
Cue Biopharma beats Q2 2025 revenue and EPS estimates, reports $2.95M revenue (-$0.09 EPS). Stock rises 2% amid FDA progress for CUE-401 autoimmune therapy.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
July 16, 2025
Via
Benzinga
Get insights into the top gainers and losers of Wednesday's after-hours session.
↗
July 16, 2025
The regular session of the US market on Wednesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
July 16, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
July 01, 2025
Via
Benzinga
What's going on in today's after hours session
↗
July 01, 2025
As the regular session of the US market concludes on Tuesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
April 15, 2025
Via
Benzinga
Discover the top movers in Monday's pre-market session.
↗
April 07, 2025
Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
April 07, 2025
Via
Benzinga
What's Going On With Cue Biopharma Shares Tuesday?
↗
April 01, 2025
Cue reported 2024 fiscal-year earnings on Monday after the market closed.
Via
Benzinga
Cue Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
March 31, 2025
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 29, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference
November 25, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights
November 14, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Announces Strategic Organizational Transition
November 14, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference
November 12, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting
November 08, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
October 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
October 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
October 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
October 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
October 04, 2024
Via
Benzinga
Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
October 04, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
October 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
September 30, 2024
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
